CVE-2025-31053

WordPress KBx Pro Ultimate plugin < 8.0.5 - Arbitrary File Deletion Vulnerability

7.7 High

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in quantumcloud KBx Pro Ultimate knowledgebase-helpdesk-pro allows Path Traversal.This issue affects KBx Pro Ultimate: from n/a through < 8.0.5.

Attack profile

How easy it is to exploit

Attack vector: Network
Complexity: Low
Privileges needed: Low
User interaction: None

What an attacker can affect

Confidentiality: None
Integrity: None
Availability: High

Exploit likelihood

0.55%Up 0.5 points since May 24, 2025

What each source reports

CVE List Score used 7.7

WordPress KBx Pro Ultimate plugin < 8.0.5 - Arbitrary File Deletion Vulnerability

Record: CVE-2025-31053
CVSS 3.1: 7.7 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:N/A:H
Weakness: CWE-22
Updated: 2026-11-02

EUVDEUVD-2025-27797 7.7

Record: EUVD-2025-27797
CVSS 3.1: 7.7 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:N/A:H
Updated: 2026-11-02

GitHub AdvisoriesGHSA-9wr9-p53c-hqrq 7.7

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in...

Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal') vulnerability in quantumcloud KBx Pro Ultimate allows Path Traversal. This issue affects KBx Pro Ultimate: from n/a through 7.9.8.

Record: GHSA-9wr9-p53c-hqrq
CVSS 3.1: 7.7 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:N/A:H
Weakness: CWE-22
Updated: 2026-11-02

NVD 7.7

Record: CVE-2025-31053
CVSS 3.1: 7.7 HighCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:N/I:N/A:H
Weakness: CWE-22
Updated: 2026-11-02

Affected products

quantumcloud kbx pro ultimate

History

History
Recorded	Changed	Sources
Nov 2, 2026	first indexed	CVE List, EUVD, GitHub Advisories, NVD

Dates are when Every CVE recorded each change. Upstream dates may differ.

In short

CVE-2025-31053 is a high vulnerability (CVSS 7.7) in Quantumcloud Kbx Pro Ultimate, published May 23, 2025. No source lists public exploit code. EPSS puts the chance of exploitation in the next 30 days at 0.55%, the 46th percentile. No source names a fixed version.